Cost for QD employees to rent an apartment in Chico, CA. $1,200/month. Please turn off your ad blocker in Quality Digest
Our landlords thank you.
Knowledge at Wharton
Published: Monday, April 16, 2018 - 12:01 America’s healthcare system has been on the examining table lately: from the tortuous battle over the Affordable Care Act, to Senator Bernie Sanders’ bill to allow low-cost prescription drugs in from Canada, to the intriguing announcement in January that Amazon, Berkshire Hathaway, and JPMorgan Chase would create an independent healthcare company for their employees. Meanwhile, less noticeably but significantly, the basic notion of “going to the doctor” is changing. During the past several years, pharmacies like CVS, Rite Aid, and Walgreen’s have been making inroads into providing basic medical services you could only get at a physician’s office (provided it was during business hours and you could make an appointment) or a hospital emergency room. During the recent Wharton Health Care Business Conference, CVS executive VP and chief medical officer Troyen Brennan shared the pharmacy giant’s plans to reshape the health care landscape. Brennan talked about the gaps in care that many Americans are struggling with, noting that there’s a shortage of primary care doctors in the United States. Several studies have predicted the shortage will only get worse, given our aging population’s increased needs. Currently in about one-third of U.S. states, only half or less of people’s primary care needs are being met, according to a recent MarketWatch report. The problem is especially bad in rural areas. Moreover, many people with private health insurance have trouble affording their deductibles. Without some sort of true innovation in the model, Brennan said, more people will simply be without insurance. “There’s a whole set of the middle class that is basically threatened by the increase in healthcare costs,” he said. Given this state of affairs, Brennan envisions an expanding role for pharmacies like CVS. He said CVS is creating a “different type of chassis” for facilitating and improving healthcare delivery. The concept is to combine data-driven insights into customers’ health with the “convenience and intimacy” of treating patients in CVS’s retail setting. The largest pharmacy chain in the United States, CVS is ubiquitous: Its bright red signs dot the landscape. It boasts nearly 9,800 retail locations in 49 states, the District of Columbia, and Puerto Rico. Brennan noted that more than 75 percent of the U.S. population lives within five miles of a CVS pharmacy. The company has already entered the healthcare arena, running more than 1,100 retail health clinics (CVS MinuteClinics) staffed by nurse practitioners and physician assistants. The providers diagnose and treat minor illnesses and injuries like strep throat and bee stings; do screenings for blood pressure, cholesterol and glucose; give vaccinations and injections; and offer wellness services, according to the company’s information. Brennan said 200 optometry and audiology centers will be added to CVS stores this year. Also under the CVS umbrella is Caremark, which is “a little more on the insurance side,” a roughly equal-sized business that does pharmacy benefit management services; Omnicare, a long-term care pharmacy services provider; and Coram, which offers home infusion. CVS is also in the process of acquiring Aetna, which would greatly expand its footprint in the insurance space. At $69 billion, the acquisition was last year’s largest, according to Reuters. The same article reported that CVS intends to have its clinics provide medical services to Aetna’s approximately 23 million medical members. In Brennan’s view, pharmacists and nurses such as those on staff at the MinuteClinics “do a much better job of communicating and are a lot more valued by individual patients than doctors.” At the same time, he emphasized that he views retail clinics as not competing with, but complementing, the services of primary care physicians. “We’re not trying to establish a different and alternative system, but one that’s basically integrated in,” he said. If the patient does have a regular doctor whom they see, that provider would be kept “completely in the loop.” He also said retail clinics can provide “a lot of basic primary care and prevention that’s not occurring today in the healthcare systems.” He asserted that supplying this care would help people stay healthier, thus driving down the nation’s high medical-cost burden. The MinuteClinic website asserts that the clinics offer “convenient, quality care at a lower cost than other healthcare providers.” A basic health screening—a review of medical history, blood pressure, and weight—runs from $59 to $69. An annual physical costs $89. Lab tests like urinalysis ($35), lipid panel ($37), and strep test ($35) are priced á la carte in conjunction with basic services. One major health issue that CVS tackles is adherence: making sure people consistently take the medicines they’re prescribed. This effort of course aligns with its role as a retail pharmacy. “We use [adherence] as our central paradigm in terms of a lot of things that we do,” Brennan said. He also talked about helping reduce hospital readmission, another costly problem: Many hospital patients who are released get sick again and end up going back in. “Often, these cases are coming out of the hospital and not seeing anybody at all; they have no other healthcare provider,” said Brennan. “We published a paper two years ago in Health Affairs showing that we decreased readmissions by 50 percent... simply by doing a comprehensive medication review with the patient.” Brennan said CVS sees a big opportunity in increasingly having its MinuteClinics monitor patients with chronic conditions: specifically asthma, COPD, depression, hyperlipidemia, hypertension, and diabetes. “They’re bad diseases, but they are very good diseases for us to be after,” he commented. These patients are already coming into a CVS store up to 15 to 20 times per month, he said, contrasting that with the average person who sees their doctor about three or four times a year. CVS could do simple biometric monitoring on a routine basis with these patients and also help with adherence, which is a “huge issue” for them. Engaging these individuals can lead to substantially better health outcomes, he said. CVS would also like to move more into the urgent care space, according to Brennan. Urgent care centers, another relatively recent healthcare phenomenon, differ from retail clinics, although many people confuse the two. The former are legally required to staff at least one board-certified physician, and they can perform X-rays and lab tests. For conditions such as sprains and strains, vomiting and diarrhea, and infections, for example, urgent care is more appropriate than a retail clinic. “Right now, we do about 65 percent of what goes on in urgent care,” Brennan noted. He said CVS intends to expand that capability so it can attract patients who would otherwise be hurrying to the hospital emergency department. While CVS plans to increase the number of nurse practitioners it hires, it’s also exploring AI options for interacting with patients to complement in-store visits. Brennan noted that AI is offering new avenues for helping patients at low cost without sacrificing quality. “If you’re [messaging with] an AI-enabled health assistant, you can’t tell that it’s not a human being,” he said. And the technology continues to improve. Also on the tech side, Brennan said CVS wants to hone its ability to glean actionable data from electronic medical records and insurance information, in order to identify healthcare needs that aren’t being met and address them from a prevention standpoint. “I think we’re just beginning to break through with regard to a machine learning approach, or deep learning approach, with the data that’s available,” he said. He believes this type of analysis will accelerate greatly during the next decade and wants CVS positioned to take advantage of it. Brennan noted that data analysis is another area in which CVS could enhance a primary doctor’s efforts. Physicians are already overwhelmed with information about patients via the electronic medical record, he said. If additional metrics are flooding in from patients’ home health monitoring devices, CVS could track them. Brennan said he expected that doctors would welcome “our ability to basically analyze that data,” as well as “intervene, keep them in the loop, bring them in when necessary.” Brennan was asked to comment on Amazon becoming a competitor. The tech powerhouse recently gained approval from at least 12 states to become a pharmaceutical distributor. Any competition or innovation is good, answered Brennan, whether it’s from Apple, Google, Amazon, or someone else, “because it forces us to do new and different things and potentially move the [healthcare] system... the right way,” he said. He noted that CVS is in the process of rolling out same-day delivery from its stores. The service is already available in selected cities and will go nationwide by the end of next year. Being able to deliver medications to people’s homes the same day they’re prescribed is a big change for CVS that he feels is important to the business. He speculated that 60 percent to 70 percent of CVS’ distribution might migrate in that direction. Home delivery aside, in Brennan’s view the proliferation of CVS’ retail stores around the country is a major strategic advantage. “You can park right next to where we are and walk in easily,” he said. “It’s the convenience factor that we’re hoping is going to lead to substantial engagement.” He commented that new entrants to the market might find it tough to beat CVS’ several thousand “physical locations already filled with people who do healthcare.” First published March 23, 2018, on the Knowledge@Wharton blog. Quality Digest does not charge readers for its content. We believe that industry news is important for you to do your job, and Quality Digest supports businesses of all types. However, someone has to pay for this content. And that’s where advertising comes in. Most people consider ads a nuisance, but they do serve a useful function besides allowing media companies to stay afloat. They keep you aware of new products and services relevant to your industry. All ads in Quality Digest apply directly to products and services that most of our readers need. You won’t see automobile or health supplement ads. So please consider turning off your ad blocker for our site. Thanks, Knowledge@Wharton is the web-based research and business analysis journal of the Wharton School of the University of Pennsylvania. Launched in May 1999, its goal is to disseminate business knowledge and insights to readers around the world. The Knowledge@Wharton Network offers free access to analysis of current business trends; interviews with industry leaders and Wharton faculty; articles based on the most recent business research; conference overviews, book reviews, and links to relevant content; and a searchable database of more than 1,500 articles and research abstracts.Can Retail Pharmacies Come to the Aid of U.S. Healthcare?
A ‘different type of chassis’ for improving healthcare delivery
Combining data with convenience
Adherence and data analysis
Fending off Amazon
Our PROMISE: Quality Digest only displays static ads that never overlay or cover up content. They never get in your way. They are there for you to read, or not.
Quality Digest Discuss
About The Author
Knowledge at Wharton
© 2023 Quality Digest. Copyright on content held by Quality Digest or by individual authors. Contact Quality Digest for reprint information.
“Quality Digest" is a trademark owned by Quality Circle Institute, Inc.